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Abstract:  Vitamin A insufficiency has profound adverse effects on embryonic 
development. Major advances in understanding the role of vitamin A in vertebrate heart 
formation have been made since the discovery that the vitamin A active form, all-trans-
retinoic acid, regulates many genes, including developmental genes. Among the 
experimental models used, the vitamin A-deficient avian embryo has been an important 
tool to study the function of vitamin A during early heart formation. A cluster of retinoic 
acid-regulated developmental genes have been identified that participate in building the 
heart. In the absence of retinoic acid the embryonic heart develops abnormally leading to 
embryolethality. 
Keywords:  vitamin A-deficient; quail embryo; retinoic acid; gene regulation;   
heart morphogenesis 
 
Abbreviations 
 
RA, all-trans-retinoic acid; VAD, vitamin A-deficient; HH, Hamburger & Hamilton developmental 
stages for avian embryo; ss, somite stage; IFT, inflow tract. 
 
1. Function of Vitamin A, Retinoic Acid, Retinoid Receptors and Gene Regulation 
 
It has been more that 80 years since the discovery of vitamin A in 1913 [1,2] and much has been 
learned about this important vitamin [3-10], but still much more remains to be done to fully understand 
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the complex functions of this micronutrient. The following minireview provides a brief overview of 
the major questions that have been answered regarding vertebrate embryonic development, with a 
focus on heart formation.  
The need for proper vitamin A nutrition throughout the life cycle is well established and involves 
the requirement for this vitamin in vision, reproduction and growth, but the molecular mechanism(s) of 
action of this micronutrient are still under investigation. Except for its role in vision, the functions of 
vitamin A are mediated by its physiologically active form, all-trans-retinoic acid (RA). The pleiotropic 
effects of vitamin A are attributable to a multitude of RA-linked transcriptional pathways involved in a 
number of cellular growth and differentiation processes [4,7,8,11]. RA functions as the ligand for 
specific nuclear transcription factors, the RA receptors RARα, β and γ [12-16] and PPAR/, the 
orphan peroxisome proliferator-activated receptor β/δ [17-19]. The RARs form heterodimers with the 
retinoid X receptors, RXRα, β and γ, and the heterodimers bind to specific RA-responsive elements in 
the target genes; their transcriptional effects (activation or repression) depend on the recruitment of 
coactivators and corepressors, respectively, in the presence or absence of retinoic acid [11,20]. The 
RARs and RXRs are known as the retinoid receptors. In addition to the transcriptional actions, RA is 
also involved in rapid nongenomic actions [13,21,22]. RA regulates more than 500 genes and is among 
the most important signaling molecules in vertebrate ontogenesis. 
 
2. Vitamin A in Embryonic Development 
 
The requirement of vitamin A for normal embryonic and fetal development is known from many 
nutritional studies [2]. It was recognized already in the 1930ies that maternal insufficiency of vitamin 
A during pregnancy results in fetal death or abnormalities in the offspring that include abnormal heart 
and central nervous system development [23-25]. While it is known that vertebrate embryos have the 
machinery for vitamin A metabolism and for the generation of all-trans-retinoic acid [26-28], the 
underlying cellular and molecular events of early embryonic development that are regulated by 
endogenous vitamin A-active molecules have not been fully elucidated.  
The origin and evolution of RA signaling during embryonic development has been traced as far 
back as the metazoans [29,30]. Both vitamin A deficiency and excess have profound adverse 
consequences on morphogenesis and organogenesis in the vertebrate embryo [9,31-40], implying that 
normally there is a tight regulation of the endogenous vitamin A-active form, all-trans-RA. 
Exogenously applied vitamin A-active compounds have been used to manipulate and perturb normal 
embryonic development, and have provided evidence that almost every organ or tissue system can be 
severely affected by RA if the embryo is treated with it at a critical time in development [39-44]. 
These studies have revealed that RA via its nuclear receptors can also regulate the expression of 
developmental genes. However, in these approaches concentrations well above endogenous levels 
were used and thus may not reflect the physiological functions of vitamin A in normal development. 
A large amount of valuable information regarding the function of vitamin A during embryonic and 
fetal development has been gathered by the use of transgenic mice with mutations or knock-outs of the 
retinoid receptor genes [7,11,45,46] as during development there is a widespread and complex 
expression of these receptors [14]. Many of the abnormalities in these mutant mice resemble those 
observed in fetuses from the vitamin A-deprived animals reported earlier. Among other important Nutrients 2010, 2                  
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approaches in the studies of molecular mechanisms of retinoid action in development is the use of in 
vivo mouse embryo model systems in which the function of vitamin A has been diminished by 
interfering with vitamin A metabolism. These approaches have added important information about RA 
function and signaling pathways in embryos and include knock-outs (KOs) of the genes for RA 
synthesizing enzymes Raldh2 [47,48], Raldh1 [49] and Raldh3 [50,51], the KOs of the RA degrading 
enzyme Cyp26 [52-54], double KO of Raldh2/Cyp26 [55], the combination KO of Cyp26b1/ RARγ  
[56] and the zebrafish Cyp26b1 mutant [57]. Another approach is to use nutritional deprivation of 
vitamin A in a rat model to obtain near-vitamin A deficiency in the dams and to target embryonal 
vitamin A insufficiency to distinct gestational windows. These rat embryos exhibit specific cardiac, 
limb, ocular, lung and central nervous system abnormalities, some of which have certain features 
similar to those reported in retinoid receptor knockout mice [9,35,58-61]. 
Altogether, while numerous studies have addressed the function of RA in embryonic development, 
the models used have resulted in diverse phenotypes because of an incomplete inactivation of RA 
signaling [62-64] or in the case of retinoid receptor knockouts, they do not provide a complete and 
clear vitamin A deficiency phenotype due to retinoid receptor redundancy [64] and the broad role of 
the RXRs as co-receptors for other nuclear receptors in non-retinoid signaling pathways [7,11]. Recent 
comprehensive reviews on the genetic dissection of retinoid signaling pathways point out the 
shortcomings of germline mutagenesis in addressing the physiological functions of vitamin A [15,65]. 
The absolute essentiality of vitamin A for early embryogenesis is unambiguously demonstrated in the 
vitamin A-deficient (VAD) avian embryo, an ideal model to study the function of vitamin A in a 
vertebrate embryo during early development. These completely VAD embryos develop gross 
abnormalities in the cardiovascular and central nervous systems and trunk and die early in embryonic 
life [31,32,66-69]. Significantly, the VAD avian embryo can be rescued and normal development 
restored by the administration of the physiological ligand for RARs, all-trans-retinoic acid, or its 
precursor, retinol, during a critical, RA-requiring time window in which important developmental 
events are specified .  
 
3. Vitamin A Deficiency, Heart Development and the Avian Embryo  
 
Maternal insufficiency of vitamin A during pregnancy results in fetal death or abnormalities in the 
offspring including abnormal heart development [23-25]. While it is generally impossible to link an 
early miscarriage or a fetal death to a specific maternal nutritional status, it is important to recognize 
the extreme sensitivity of the very early embryonic genome to epigenetic influences, including those of 
maternal environment. This is particularly relevant when discussing cardiovascular development since 
pediatric cardiovascular abnormalities account for 8% of all deaths during the first year of life, and 
congenital heart defects in the Western world are as high as 12/1000 live births, representing the 
majority of all congenital malformations [70-73]. The etiology of these malformations is largely 
unknown, but inadequate or inappropriate nutritional cues during early heart morphogenesis are likely 
contributors to these birth defects. This has been clearly evidenced in cases of insufficient folate 
supplementation during pregnancy which leads to neural tube defects in newborn. While a genetic 
predisposition to congenital heart disease is likely present in certain cases, it is also likely that another Nutrients 2010, 2                  
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insult such as vitamin A insufficiency or a disturbance in vitamin A metabolism or function during 
embryogenesis, contributes to the cardiovascular defects observed clinically. 
Vitamin A deficiency is not prevalent in the U.S. but marginal insufficiency or disturbances in 
vitamin A metabolism such as may be caused by environmental pollutants or alcohol abuse during 
pregnancy, are important risk factors. It is, however very difficult to demonstrate the link of vitamin A 
insufficiency in the mother to congenital abnormalities in the offspring, as vitamin A requirement 
begins very early during embryogenesis and involves many genes that critically impact early 
development.  Presently there is no understanding of the molecular basis of cardiovascular birth 
defects. The critical vitamin A-requiring developmental events that take place in the early avian 
embryo during heart formation [67] coincide with the first 2-3 weeks of human pregnancy and may be 
severely compromised if maternal vitamin A intake is marginal or if there is interference with vitamin 
A function during pregnancy. The high incidence of vitamin A deficiency in developing countries may 
account for the increased incidence of heart malformations in these populations [74]. The WHO 
reports that millions of pregnancies yearly are carried by women with insufficient vitamin A   
nutrition [75]. 
The cardiovascular system is the first physiologically functioning organ system to form in the 
embryo. The development of the embryo is critically dependent on a normal and functional 
development of this system so as to obtain nutrients and growth factors. While it has been well 
documented that vitamin A-active compounds have an important role in heart development [32,34,76-
78], the underlying morphological, cellular and molecular events of early embryonic development that 
are regulated by endogenous vitamin A-active molecules have not been elucidated. In order to prevent 
or ameliorate cardiovascular birth defects that may be caused by disturbances in vitamin A function or 
insufficiency during early development, it is imperative to understand how vitamin A works during the 
formation of the heart and the vascular system. An excellent recent review offers the most up-to-date 
information on the role of vitamin A in mammalian heart development, and describes the major 
discoveries at the gene level that have been made with the use of rodent models at various selected 
stages of heart morphogenesis [78].  
The purpose of the present minireview is to point out the advances that have been made regarding 
the role of vitamin A in the very early events of vertebrate vasculogenesis and heart formation, not 
addressed in the mammalian models. This research has been possible with the use of a novel vitamin 
A-deficient (VAD) avian (quail) embryo model in which one can examine biological actions at cellular 
and molecular levels attributable solely to vitamin A. Our laboratory has utilized this model for the in 
vivo examination of the physiological function of vitamin A in vertebrate embryogenesis with a focus 
on early cardiovascular development; the following advances have been made: a). The confirmation of 
the absolute dependency on the presence of vitamin A for the morphogenesis of the cardiovascular 
system and for avian embryo survival [79] that had been observed earlier [3,80]. The hallmark of 
vitamin A deficiency in the avian embryo is a grossly abnormal cardiovascular system, characterized 
by an absence of vascular networks and by a ballooned, non-compartmentalized, randomly-positioned 
heart, without an inflow tract at the posterior site of the heart [79]; these embryos die by embryonic 
day four; b). The discovery of a critical time window when the presence of RA is absolutely essential 
for normal embryogenesis to proceed; this time coincides with the initiation of heart morphogenesis 
and the organization of endothelial cells into vascular networks [67] and corresponds to the first   Nutrients 2010, 2                  
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2–3 weeks of human pregnancy. If RA is administered to the VAD quail embryo during this critical 
time or prior to it, the embryo is rescued and develops normally. It is important to note that severe 
cardiac malformations are observed in an estimated 10% of early miscarriages [73]; some of them may 
be linked to disturbances in vitamin A function during the early critical time of heart formation;   
c). The identification of a cluster of developmental genes that are regulated by RA during early heart 
formation; they include the cardiac transcription factor GATA4 [68], the heart asymmetry genes 
Nodal, Snail and Pitx2 [66], the global growth factor Bmp2 [81], the adhesion molecule N-cadherin 
[82] and the global growth regulator TGFβ2 [83]; and d). The discovery that all retinoid receptors are 
expressed in the early avian embryo (67, 84-86), but that during the critical RA-requiring 
developmental window RAR2, RAR and RXR are the active transcription factors transducing the 
RA signal to target genes [84,85].  
 
4. Vitamin A is Required to Build the Link Between the Primordial Heart and its Blood Supply 
 
Building of the heart is one of the many complex morphogenetic events during embryogenesis; it is 
coordinated by numerous growth regulatory molecules, including RA. In the VAD avian embryo, the 
predominant feature of the VAD phenotype is a failure of cardiovascular development, with embryo 
lethality linked directly to the absence of the cardiac inflow tracts, i.e., these embryos lack the sino 
atrial tissue and their hearts are closed posteriorly, thus there is no blood supply to the embryo 
[32,79,80]. The administration of RA or retinol during or prior to the critical developmental time 
window when RA requirement begins in the early avian embryo (i.e., the HH8 4/5 somite stage) 
rescues the VAD embryo, and it now develops with a completely normal phenotype [66-68]. 
The absence of a connection of the extraembryonal blood supply to the forming heart in the 
developing VAD heart pointed to a critical role for vitamin A in building the posterior heart and led to 
the hypothesis that the cardiovascular abnormalities associated with the VAD embryonic phenotype 
and the inevitable embryolethality are initially linked to an inability to form the heart inflow tracts 
(IFTs) in the absence of vitamin A. The building of the IFTs is a crucial event in early cardiogenesis 
and cardiovascular development. Vertebrate heart morphogenesis begins in the posterior heart forming 
region and proceeds anteriorly. The formation of the connection between the primordial heart and the 
extraembryonal vasculature is the first event that takes place in heart development; it occurs at the site 
of the formation of the future heart IFTs in the posterior region of the primordial heart. It is this event 
that lays the structural foundation for a subsequent normal heart morphogenesis. The devastating 
impact of the failure to form this linkage is clearly evidenced by the embryolethality of the VAD quail 
embryo [31,32]. 
Building of the heart IFTs involves cells from different lineages [87,88], and also includes the 
formation of the incoming blood vessels [89], which converge into vitelline veins at the posterior 
regions of the developing heart. The studies in our laboratory have been directed to more fully 
elucidate the embryonic molecular environment during early development that is required for the 
successful building of the heart IFTs. Presently there is a gap in the general knowledge regarding the 
formation of the cardiac IFTs, while there is an abundance of data describing the events subsequent to 
posterior heart formation [78]. Although the potential role of RA in this process has been discussed 
[90,91] the models used did not allow for an evaluation of the physiological role of RA at the very Nutrients 2010, 2                  
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early stages of heart morphogenesis; this has been possible with the use of the completely VAD 
vertebrate embryo, the avian embryo.  
It is very difficult to clinically link vitamin A function to the important early event of cardiac IFT 
formation, since no specific birth defects or cardiovascular malfunctions in neonates or adults have 
been attributed to a faulty formation of the heart IFTs. However, it is of great importance to recognize, 
as our work suggests, that it is very likely that if severe malformations had occurred during early heart 
morphogenesis at the sites of the developing IFTs, they would have led to embryo lethality, thus no 
information about the specific cause of the death of such embryo would be available. Supporting this 
possibility are the observations that severe cardiac malformations are associated with an estimated 
10% of early miscarriages [73]; some of them may be linked to disturbances in vitamin A function 
during the early critical time in heart formation. 
Evidence for the importance of vitamin A in building the heart IFTs is based on the following 
discoveries in our laboratory: a) In the VAD embryo the cardiac IFTs do not form [31,32,79]; b) The 
cardiogenic transcription factor GATA4, normally expressed in the early developing heart, is severely 
diminished in the VAD embryo in the posterior heart forming regions at the sites of the future IFTs 
[68,81]. However, cardiomyocyte differentiation is not altered and the primitive heart tube forms in 
these VAD embryos, thus providing evidence that RA signaling is not required for these early heart 
morphogenesis events [68];  c) Additional support for the role of vitamin A in IFT building was 
obtained from the localization of Raldh2, the main RA synthesizing enzyme, in the posterior heart 
region during quail embryogenesis [85] and from the demonstration of expression of all retinoid 
receptors in the heart forming regions of quail embryos [67,84-86]; and d) A systematic examination 
of the early development in the VAD quail embryos revealed that in these embryos one of the earliest 
observable morphological defects is an abnormal formation of the heart IFTs which gradually become 
more narrow and finally close up, thus resulting in the absence of a connection between the developing 
heart and the extraembryonal blood supply to the heart [82]. 
 
5. Molecules Involved in Retinoic Acid-Regulated Building of the Heart Inflow Tracts  
 
Many signaling pathways participate in the important and complex interactions to form a heart. The 
successive activation of different sets of genes for heart morphogenesis is by specific transcription 
factors and include Nkx2.5, Hox, Msx1 & 2 and GATA4/5/6 [92,93]. Since we already knew that the 
critical RA requirement is at the HH8 4/5 somite stage during neurulation and since this is also the 
time window when embryonic cell terminal differentiation is determined, our studies have focused on 
cellular and molecular events taking place at this developmental time and during the immediate events 
just prior to and just subsequent to it, but before heart chamber segmentation and formation of blood 
flow, so as to avoid secondary effects. 
We have identified the following cluster of molecules that are regulated by RA during IFT 
formation: a) The retinoid receptors, which are also transcription factors, are expressed in the heart 
forming areas of the early quail embryo [84], but in the VAD embryos the expression of the RA 
receptor RAR2 is severely decreased in these regions [84]; blocking the expression of this receptor in 
normal embryos interferes specifically with the formation of IFTs [85] providing evidence for a 
specific role of RARα2 in regulating heart IFT morphogenesis; b) The cardiogenic transcription factor Nutrients 2010, 2                  
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GATA4 may be a contributor to RA-regulated IFT formation, as normally GATA4 transcripts are 
particularly high in the posterior heart region [94], but in the VAD quail embryos they are severely 
diminished at these sites [68]; and c).The overexpression of N-cadherin [82] and TGFβ2 [83] observed 
in VAD quail embryos, is linked to the abnormal heart IFT formation; this is discussed in the 
following sections.  
From the above evidence it becomes clear that it is for the morphogenesis of the heart posterior 
region that the initial RA signaling input at molecular level is required for a subsequent normal cardiac 
morphogenesis and a normal embryonic development to take place, and that the abnormal 
cardiovascular phenotype associated with vitamin A deficiency in the avian embryo is the consequence 
of an initially disrupted program for posterior heart morphogenesis. 
  
6. Retinoic Acid Regulates N-cadherin During Early Heart Formation [82] 
 
Our recent work on the function of RA in heart IFT formation addresses the cell adhesion molecule 
N-cadherin (N-cad). Cell-cell and extracellular matrix interactions profoundly influence many 
signaling events, including cell migration, mitogenesis, apoptosis and differentiation, all of these 
events required for the morphogenesis of the heart. Thus we next examined the interrelationship 
between RA and N-cad, since this molecule is crucial for heart formation [88,95-99], including 
establishing cardiac left-right asymmetry [100], which is also regulated by RA [66]. The endocardial 
and mesodermal cells in the posterior parts of the cardiac crescent participate in the remodeling of the 
posterior heart and involve N-cad mediated cellular organization [88,99]. Vitamin A via RA has 
pleiotropic functions and thus is likely to participate in any one of these processes. These 
considerations led to the studies with N-cad and the discovery that RA regulates N-cad [82]. N-cad 
mRNA and protein were found to be expressed globally in the presomite through HH14 normal and 
VAD quail embryos, but the expression in VAD embryos in the early stages prior to HH10 was 
significantly higher than that in normal embryos, indicating that RA negatively regulates N-cad at 
these developmental stages. Functional analyses of the N-cad overproducing VAD embryos revealed 
that N-cad is involved in several RA-regulated cardiovascular events, i.e., IFT morphogenesis, 
vascularization and cardiac looping, but not in the regulation of heart asymmetry. While the 
mechanisms remain to be elucidated, it is possible that too much N-cad disturbs mesodermal cell 
organization, since an excess of N-cad can interfere with cell movement and limit migration [95]. 
In order to obtain clues about the mechanism of the RA and N-cad relationship, we examined the 
time course of N-cad gene repression by the administration of physiological amounts of RA to VAD 
embryos. These studies revealed that RA does not exert a direct effect on the N-cad gene, as 
approximately 2 h elapsed before the in ovo administration of RA to the VAD embryo caused a 
normalization of the overexpressed N-cad gene. About 30–45 min are required for RA to induce 
transcription in the VAD embryo of a direct RA target gene (with RARE), such as RARα2 [84]. If 
RARα2 were the receptor involved in regulating N-cad expression, an altered expression of N-cad 
should have been seen in less than 2 hours. These observations suggest that RA exerts its effect on  
N-cad by an indirect mechanism, i.e., that downstream of RA there exists a signaling pathway which, 
upon the activation by RA, regulates N-cad. Nutrients 2010, 2                  
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In further studies we obtained evidence that N-cad expression may be mediated by Msx1. The 
homeobox transcription factor Msx1 is known to be involved in heart morphogenesis [101,102]. 
Earlier we had observed that this gene is ectopically expressed in the heart forming regions of the 
VAD quail embryo [103]. Since Msx1 and N-cad both were found to be overexpressed in the VAD 
embryo during early heart morphogenesis and since N-cad mediated cell adhesion and cell sorting is 
known to be regulated by Msx1 [104], it was of great interest to determine if the excessive expression 
of N-cad in the VAD quail embryo is mediated by Msx1. The approach was to block the ectopic Msx1 
expression in VAD embryos with antisense oligonucleotides specific to Msx1 and then assess N-cad 
gene expression. When the ectopically expressed Msx1 gene was blocked in the VAD embryo, this 
also resulted in blocking the excessive expression of N-cad. From these findings we proposed that RA 
normalizes N-cad overexpression in VAD embryos by an indirect pathway that may be mediated by 
Msx1. Msx1 is sensitive to the regulation by RA, as the promoter in Msx1 has been found to have an 
enhancer responsible for RA induction [105]; there is also a possible binding site for RAR/RXR [106], 
as well as several transcription factor binding sites for RAR, RXR and the RAR/RXR heterodimers 
[107], but the structure of a RARE in this promoter has not been fully characterized. Additionally, the 
Msx1 promoter also has AP-1 sites [106,107], where RA/RAR can block Msx1 expression. RA is a 
well-known negative regulator of AP-1 responsive genes [108] and a potent inhibitor of AP-1 
mediated growth signals [6,11]; suggested mechanisms include RA/RAR competing for coactivator 
proteins [109], RA/RAR disrupting cjun/cfos dimerization and RA/RAR inhibiting cjun 
phosphorylation [110]. These potential mechanisms could explain how the absence of RA results in 
Msx1 overexpression in the VAD embryo.  Since  Msx genes have been linked to avian cardiac 
development [111] and to the regulation of N-cad [104], the interrelationship between RA, Msx1 and 
N-cad warrants further examination. 
The Msx genes are multifunctional patterning genes, expressed at sites where apoptosis occurs 
[112] and thus are strongly implicated as transcriptional regulators of apoptosis during development 
[113]. Apoptosis is a normal and prominent factor in ridding the embryo of cells which have fulfilled 
their function in morphogenesis; this also takes place during heart development [114]. The altered 
morphogenesis of the posterior heart region as well as the sparse vascular networks characteristic of 
the VAD embryo [82,89,115] may involve an increased apoptosis, since Msx1, an apoptosis gene, is 
upregulated in the VAD embryo [82,103]. This idea is supported by the observations of increased 
apoptosis in the VAD embryo in the central nervous system, the somites [116,117] and in the foregut 
[118]. Thus it is possible that Msx1 is affecting two different downstream signaling pathways, i.e., one 
that regulates N-cad and another that is involved in apoptosis, both participating in the RA-regulated 
morphogenesis of cardiac inflow tracts.  
A very important observation in these studies is that in the early avian embryo endogenous RA is a 
negative physiological regulator of both Msx1 and, indirectly, of N-cad. We hypothesize that a critical 
endogenous level of N-cad is needed for normal early cardiovascular morphogenesis to occur and that 
this level is ensured by a stage-specific, developmentally regulated RA signaling. While such negative 
regulation by RA is the first observation regarding the N-cadherin gene, the potential for RA to be 
either a positive or a negative regulator is well known from in vitro studies and from observations that 
the transcriptional effects (activation or repression) of the retinoid receptors depend on the recruitment 
of coactivators and corepressors, respectively, in the presence or absence of RA [11,20]. Our studies Nutrients 2010, 2                  
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have now confirmed such negative regulation also in the in vivo vertebrate embryo but the mechanisms 
remain to be elucidated.  
 
7. TGFβ2 is Negatively Regulated by Endogenous Retinoic Acid during Early Heart Formation 
 
Our most recent studies have focused on TGFβ2 as a major regulatory target of RA during early 
embryonic development [83]. It is well known that TGFβs and RA share global growth regulatory 
characteristics, e.g., modulation of cell proliferation, apoptosis and differentiation [4,6]. Our 
observations that the entire VAD quail embryo phenotype can be rescued by the administration of RA 
during the vitamin A-sensitive developmental window [32,67,68], suggested that RA-regulated early 
cardiovascular morphogenesis is implemented by global growth factors such as TGFβs, as they 
regulate many developmental pathways. Futhermore, it is also well known that in many cells RA 
regulates TGFβ signaling [4,119-123], with TGFβ2 being the most sensitive isoform to tissue retinoid 
levels [124]. The above rationale led to testing the idea that RA regulates TGFβ2 signaling during in 
vivo embryonic heart development. The role of TGFβ2 in heart development at the time of initiation of 
heart morphogenesis had not been investigated in an in vivo vertebrate embryo nor in the context of an 
interaction with physiological levels of RA. In our work with TGFβ2 [83] we made the following 
important and novel observations: a) Endogenous RA is a critical negative in vivo regulator of TGFβ2 
during early avian embryogenesis, evidenced by the overexpression of TGFβ2 in the VAD embryo. 
We hypothesize that the negative regulation of TGFβ2 by RA is via the AP-1 site in the TGFβ2 
promoter [125]; b) RA regulation of TGFβ2 during early heart morphogenesis is at the level of 
transcription; for this RA-regulated activity TGFβ2 utilizes a Smad-independent pathway; and c) The 
use of the VAD avian embryo model revealed a major role of TGFβ2 in posterior heart development. 
We propose that during the early physiological events of vertebrate cardiovascular development a 
strictly regulated TGFβ2 activity by endogenous RA is essential for the initial heart IFT 
morphogenesis to take place involving the link-up of the primitive heart tube to the extraembryonal 
vasculature. These events are followed by the positioning of the heart tube to the right side and its 
subsequent looping. The events are separate and independent, and likely involve other developmental 
signals. Clearly, TGFβ2 is an important participant in the complex network of factors required for 
early heart morphogenesis. Some cardiovascular pathologies that are associated with elevated levels of 
TGFβ2 [126,127] may be linked to disturbed RA function during pregnancy.  
 
8. Summary and Conclusions  
 
Many important questions about vitamin A have been answered since its discovery, and much has 
been learned about the effects of maternal vitamin A deficiency on fetal heart development [33,128]. 
Studies with rodent models [9,45-58,63,76,78,128-133] have significantly added to our understanding 
of the role of vitamin A in vertebrate heart formation, particularly during the later stages of heart 
morphogenesis, after the initial formation of the posterior heart when the heart inflow tracts link up 
with the extraembryonal vasculature. The studies with the avian embryo model, reviewed here, have 
extended the existing knowledge of vertebrate heart morphogenesis by providing insights into the 
essential role of vitamin A for the very early events in this complex process.  Nutrients 2010, 2                  
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Clearly, the complexity of cardiovascular development mandates that we analyze multiple gene 
pathways to evaluate the role of vitamin A and to lay the groundwork for subsequent mechanistic 
studies. Using the avian model  we have identified a cluster of downstream effectors of the RA 
signaling pathways involved in vertebrate early cardiovascular morphogenesis. They include the heart 
asymmetry genes Nodal, Snail and Pitx2, the cardiogenesis transcription factor GATA4, linked to 
Bmp2. The retinoid receptor RARα2 is specifically linked to heart inflow tract formation, while RARγ 
is linked to heart asymmetry and looping. The cell-cell adhesion molecule N-cadherin is involved in 
several aspects of heart morphogenesis, including inflow tract formation, heart looping and 
vascularization, and in these events may be regulated by Msx1. TGFβ2 was found to be a major 
contributor to RA-regulated posterior heart morphogenesis. Importantly, RA was identified as a 
negative physiological regulator of the global growth factors N-cadherin and TGFβ2 during early heart 
formation. Potential RA signaling pathways involved in building the early embryonic heart are illustrated in 
Figure 1. 
Figure 1. Potential retinoic acid signaling pathways involved in building the early 
embryonic heart. Retinoic acid (RA) is an embryonic morphogen, participating in heart 
morphogenesis. The effects of RA are mainly mediated by RA as the ligand for the 
transcription factors RARs. TGFβ2 [125] and Msx-1 [106,107] both have AP-1 sites in 
their promoters, that are negatively regulated by RA/RAR blocking AP-1 activity 
[6,11,125]. Potential binding sites for RAR/RXR have been identified in the Msx1 
promoter [105-107]. Genes containing the RA responsive element, RARE, such as Bmp2 
[137], are direct RA target genes, regulated by RA/RAR/RXR heterodimers. The potential 
signaling pathways are based on research data obtained in M. Zile’s laboratory [83]. 
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The elucidation of the pleiotropic functions of RA during embryonic development remains an active 
field of investigation. We are continuing the characterization of vitamin A-regulated genes involved in 
the formation of the early heart and the vascular system. Since early vertebrate embryonic heart 
development is similar across the species, including the human, many analogies can be drawn from 
such studies. Although much more work is needed to completely elucidate the role of vitamin A in 
heart formation, the presently available data provide strong, evidence-based information emphasizing 
the importance of an adequate and functional vitamin A environment during early pregnancy. 
Understanding the molecular role of vitamin A in early embryonic and fetal events is imperative in 
developing intervention strategies during human in utero development so as to decrease the incidence 
of cardiovascular birth defects and thus minimize problems that are likely to arise during adult life 
from an unfavorable in utero environment. The exploration of origins of disease and various 
pathologies as linked to the environment of vitamin A and other micronutrients during critical early 
stages of embryonic development is only recently gaining a momentum [128,134,135]. The present 
minireview has illustrated the essential role of the micronutrient vitamin A for a specific but very 
critical early developmental event in building the embryonic heart. However, it is important to 
remember that the cardiovascular system is only one of many developmental events that require a 
regulatory input by vitamin A [128]. Finally, it is the overall nutritional experience and environment of 
the early embryo and fetus that determines the health status of the offspring [128,136].  
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